Will targeted mutagenisis suffer less regulatory overkill than transgenic approaches?

 "Reduction in regulatory costs would make it economically feasible for smaller biotechnology companies to produce improvements that would otherwise be overlooked by large corporations, such as improved health characteristics in soybean oil, as this article will discuss "

ISB News Report, October 2014 PLANT RESEARCH NEWS

Creation of High Oleic Soybean Oil via Targeted Mutagenesis of FAD2 Gene Family

Thomas Stoddard, Daniel F Voytas, Luc Mathis, and Feng Zhang

GE crops for human consumption date back 10,000 years to the advent of sedentary agriculture when humans first began selecting and breeding the most beneficial plants. Technological advances have improved breeding techniques, which have helped to reduce the time and labor involved; however, the resulting plants are nearly always transgenic. The advent of sequence-specific nucleases has allowed for accurate and precise genome engineering, reducing both the labor and time investment without requiring the integration of foreign DNA into the genome. This utility of the technology was exemplified recently with the development of a soybean line that produces high oleic acid oil and lacks any foreign DNA.

@ (Full article pdf file)